Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Arena Pharmaceuticals Inc buy melinda

Start price
€36.80
03.01.18 / 50%
Target price
€40.59
21.03.18
Performance (%)
10.83%
End price
€40.79
21.03.18
Summary
This prediction ended on 21.03.18 with a price of €40.79. The BUY prediction by melinda finished with a performance of 10.83%. melinda has 50% into this prediction

Arena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.

Performance without dividends (%)
Name 1w 1m 1y 3y
Arena Pharmaceuticals Inc - - - -
iShares Core DAX® 1.080% -2.131% 14.264% 15.290%
iShares Nasdaq 100 0.362% 7.059% 35.383% 56.103%
iShares Nikkei 225® -1.155% -0.483% 8.258% 4.324%
iShares S&P 500 0.806% 5.037% 29.635% 49.529%

Comments by melinda for this prediction

In the thread Arena Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 10.83%
Target price 40.590
Change
Ends at 21.03.18

Biotechnologie und Medizintechnik SecteurRecherche Agenda 10/01 | 23.30



Beruf
Logo Arena Pharmaceuticals, Inc
Erforscht, entwickelt und vermarktet Medikamente

Arena Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen, das sich auf die Entdeckung, Entwicklung und Vermarktung neuartiger Medikamente, die protien G-gekoppelte Rezeptoren abzielen.

Es bietet eine Reihe von Medikamenten für die Behandlung im Bereich der Herz-Kreislauf, zentrales Nervensystem, Entzündungen und Stoffwechselerkrankungen.

Das Unternehmen wurde 14 von Dominic P. Behan und Jack Lief am April 1997 gegründet und befindet sich in San Diego, CA. Sitz

Anzahl der Mitarbeiter: 106 Personen.



Prediction Buy
Perf. (%) 10.83%
Target price 40.590
Change
Ends at 21.03.18

(Zielkurs erreicht)

Stopped prediction by melinda for Arena Pharmaceuticals Inc

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€53.00
21.05.20
€60.00
04.11.21
2.83%
05.11.21

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€48.59
26.05.19
€90.20
22.07.19
15.78%
22.07.19

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€43.57
20.09.13
€50.00
20.03.14
8.10%
20.03.14

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€17.07
21.12.10
€20.00
23.12.10
-22.09%
23.12.10

buy
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€15.53
18.09.10
€30.00
21.12.10
12.69%
21.12.10